col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Public Library of Science: PLoS Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―25 Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform Krishnan Bhaskaran, Christopher T. Rentsch, George Hickman, William J. Hulme, Anna Schultze, Helen J. Curtis, et al. (+27)
2 [GO] 2022―Jan―25 Pandemic health consequences: Grasping the long COVID tail Kieran L. Quinn, Chaim M. Bell
3 [GO] 2022―Jan―10 Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study Ipek Gurol-Urganci, Lara Waite, Kirstin Webster, Jennifer Jardine, Fran Carroll, George Dunn, et al. (+7)
4 [GO] 2022―Jan―06 Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink Helen Strongman, Helena Carreira, Bianca L. De Stavola, Krishnan Bhaskaran, David A. Leon, Sanjay Basu
5 [GO] 2021―Dec―29 Correction: Social determinants of mortality from COVID-19: A simulation study using NHANES Benjamin Seligman, Maddalena Ferranna, David E. Bloom
6 [GO] 2021―Dec―20 Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, Evan M. Bloch, Noud van Helmond, Michael A. Golafshar, et al. (+53)
7 [GO] 2021―Dec―17 Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, et al. (+3)
8 [GO] 2021―Dec―16 Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, Joel A. Malek, Ayeda A. Ahmed, et al. (+19)
9 [GO] 2021―Dec―10 Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study Manoj V. Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, V. Saravanakumar, Muthusamy Santhosh Kumar, Sriram Selvaraju, et al. (+25)
10 [GO] 2021―Dec―09 SARS-CoV-2 vaccine boosters: The time to act is now Maya Petersen, Joshua Schwab, Diane V. Havlir
11 [GO] 2021―Dec―06 Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study Shelly Karuna, Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia, et al. (+10)
12 [GO] 2021―Nov―30 Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study Sylvie Epelboin, Julie Labrosse, Jacques De Mouzon, Patricia Fauque, Marie-José Gervoise-Boyer, Rachel Levy, et al. (+8)
13 [GO] 2021―Nov―29 COVID-19 in Africa: Catalyzing change for sustainable development Salim S. Abdool Karim, Segenet Kelemu, Cheryl Baxter
14 [GO] 2021―Nov―23 Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study Marije J. Splinter, Premysl Velek, M. Kamran Ikram, Brenda C. T. Kieboom, Robin P. Peeters, Patrick J. E. Bindels, et al. (+6)
15 [GO] 2021―Nov―05 SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study Christopher A. Martin, Colette Marshall, Prashanth Patel, Charles Goss, David R. Jenkins, Claire Ellwood, et al. (+6)
16 [GO] 2021―Oct―21 Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study George N. Ioannou, Jacqueline M. Ferguson, Ann M. O’Hare, Amy S. B. Bohnert, Lisa I. Backus, Edward J. Boyko, et al. (+9)
17 [GO] 2021―Oct―14 HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study Rita Bergqvist, Viktor H. Ahlqvist, Michael Lundberg, Maria-Pia Hergens, Johan Sundström, Max Bell, et al. (+2)
18 [GO] 2021―Oct―13 Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study Yin Mo, David W. Eyre, Sheila F. Lumley, Timothy M. Walker, Robert H. Shaw, Denise O’Donnell, et al. (+5)
19 [GO] 2021―Oct―13 Correction: Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis
20 [GO] 2021―Oct―12 Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial Simon Gilbody, Elizabeth Littlewood, Dean McMillan, Carolyn A. Chew-Graham, Della Bailey, Samantha Gascoyne, et al. (+20)
21 [GO] 2021―Oct―04 COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness Carl A. B. Pearson, Fiammetta Bozzani, Simon R. Procter, Nicholas G. Davies, Maryam Huda, Henning Tarp Jensen, et al. (+8)
22 [GO] 2021―Oct―01 COVID-19 and global equity for health: The good, the bad, and the wicked Elvin H. Geng, Michael J. A. Reid, Eric Goosby, Quarraisha Abdool-Karim
23 [GO] 2021―Oct―01 Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial Neil Formica, Raburn Mallory, Gary Albert, Michelle Robinson, Joyce S. Plested, Iksung Cho, et al. (+4)
24 [GO] 2021―Sep―28 Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people Joshua Elliott, Matthew Whitaker, Barbara Bodinier, Oliver Eales, Steven Riley, Helen Ward, et al. (+5)
25 [GO] 2021―Sep―28 Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 Maxime Taquet, Quentin Dercon, Sierra Luciano, John R. Geddes, Masud Husain, Paul J. Harrison, Mirjam E. E. Kretzschmar
26 [GO] 2021―Sep―13 Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed J Peter Figueroa, Peter J. Hotez, Carolina Batista, Yanis Ben Amor, Onder Ergonul, Sarah Gilbert, et al. (+15)
27 [GO] 2021―Aug―31 Building global health research capacity to address research imperatives following the COVID-19 pandemic Peter H. Kilmarx, Roger I. Glass
28 [GO] 2021―Aug―12 Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis Lukas E. Brümmer, Stephan Katzenschlager, Mary Gaeddert, Christian Erdmann, Stephani Schmitz, Marc Bota, et al. (+10)
29 [GO] 2021―Jul―13 Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study Sasikiran Kandula, Jeffrey Shaman, Richard Turner
30 [GO] 2021―Jul―06 Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, et al. (+15)
31 [GO] 2021―Jul―06 SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, David Ross Darley, Deepti Pilli, Daniele Vitale, et al. (+23)
32 [GO] 2021―Jul―01 Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis Giorgia Sulis, Brice Batomen, Anita Kotwani, Madhukar Pai, Sumanth Gandra, Gwenan M. Knight
33 [GO] 2021―Jun―24 Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19 Wenhui Mao, Osondu Ogbuoji, David Watkins, Ipchita Bharali, Eric Boateng, Mohamed Mustafa Diab, et al. (+9)
34 [GO] 2021―Jun―23 COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control Seth C. Inzaule, Pascale Ondoa, Marguerite Massinga Loembe, Yenew Kebede Tebeje, Ahmed E Ogwell Ouma, John N. Nkengasong
35 [GO] 2021―Jun―07 Correction: Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic
36 [GO] 2021―Jun―01 Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study Guillaume Butler-Laporte, Tomoko Nakanishi, Vincent Mooser, David R. Morrison, Tala Abdullah, Olumide Adeleye, et al. (+11)
37 [GO] 2021―May―24 Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity Michel Goldman, Cédric Hermans
38 [GO] 2021―May―20 COVID-19 and excess mortality in the United States: A county-level analysis Andrew C. Stokes, Dielle J. Lundberg, Irma T. Elo, Katherine Hempstead, Jacob Bor, Samuel H. Preston, Amitabh Bipin Suthar
39 [GO] 2021―Apr―22 Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic Seye Abimbola, Sumegha Asthana, Cristian Montenegro Cortes, Renzo R. Guinto, Desmond Tanko Jumbam, Lance Louskieter, et al. (+7)
40 [GO] 2021―Mar―11 How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities Michael Reid, Quarraisha Abdool-Karim, Elvin Geng, Eric Goosby
41 [GO] 2021―Mar―04 Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis Aaron Leong, Joanne B. Cole, Laura N. Brenner, James B. Meigs, Jose C. Florez, Josep M. Mercader, Sébastien Theriault
42 [GO] 2021―Mar―03 Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, et al. (+27)
43 [GO] 2021―Feb―04 Correction: Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study Mary T. Bassett, Jarvis T. Chen, Nancy Krieger
44 [GO] 2021―Jan―12 Social determinants of mortality from COVID-19: A simulation study using NHANES Benjamin Seligman, Maddalena Ferranna, David E. Bloom, Mirjam E. E. Kretzschmar
45 [GO] 2020―Dec―30 Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis Min Seo Kim, Min Ho An, Won Jun Kim, Tae-Ho Hwang, Mirjam E. E. Kretzschmar
46 [GO] 2020―Dec―29 Correction: Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
47 [GO] 2020―Dec―04 Correction: Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study
48 [GO] 2020―Oct―30 Acute kidney injury associated with COVID-19: A retrospective cohort study Nitin V. Kolhe, Richard J. Fluck, Nicholas M. Selby, Maarten W. Taal, Giuseppe Remuzzi
49 [GO] 2020―Oct―23 Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
50 [GO] 2020―Oct―20 Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study Paul M. McKeigue, Amanda Weir, Jen Bishop, Stuart J. McGurnaghan, Sharon Kennedy, David McAllister, et al. (+12)
51 [GO] 2020―Oct―20 Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study Mary T. Bassett, Jarvis T. Chen, Nancy Krieger, Alexander C. Tsai
52 [GO] 2020―Oct―06 Correction: Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study Mark J. Siedner, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Sebastien Haneuse, Atheendar S. Venkataramani, Alexander C. Tsai
53 [GO] 2020―Oct―01 Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study Janine Makaronidis, Jessica Mok, Nyaladzi Balogun, Cormac G. Magee, Rumana Z. Omar, Alisia Carnemolla, et al. (+2)
54 [GO] 2020―Sep―22 Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study Christopher T. Rentsch, Farah Kidwai-Khan, Janet P. Tate, Lesley S. Park, Joseph T. King, Melissa Skanderson, et al. (+11)
55 [GO] 2020―Sep―22 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis Diana Buitrago-Garcia, Dianne Egli-Gany, Michel J. Counotte, Stefanie Hossmann, Hira Imeri, Aziz Mert Ipekci, et al. (+3)
56 [GO] 2020―Sep―17 Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) Sophie Juul, Emil Eik Nielsen, Joshua Feinberg, Faiza Siddiqui, Caroline Kamp Jørgensen, Emily Barot, et al. (+9)
57 [GO] 2020―Sep―14 Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study Julia Stowe, Nick Andrews, Paul Gringras, Timothy Quinnell, Zenobia Zaiwalla, John Shneerson, et al. (+2)
58 [GO] 2020―Sep―10 Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis Stephanie L. Harrison, Elnara Fazio-Eynullayeva, Deirdre A. Lane, Paula Underhill, Gregory Y. H. Lip, Mirjam E. E. Kretzschmar
59 [GO] 2020―Sep―08 Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study Lars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, Steffen Christensen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, et al. (+6)
60 [GO] 2020―Sep―03 COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology Nicholas J. White, James A. Watson, Richard M. Hoglund, Xin Hui S. Chan, Phaik Yeong Cheah, Joel Tarning
61 [GO] 2020―Aug―28 The reimagination of school-based physical activity research in the COVID-19 era Deirdre M. Harrington, Michelle O’Reilly
62 [GO] 2020―Aug―11 Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study Mark J. Siedner, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Sebastien Haneuse, Atheendar S. Venkataramani, et al. (+2)
63 [GO] 2020―Jul―28 Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China Yan-Ting Wu, Jun Liu, Jing-Jing Xu, Yan-Fen Chen, Wen Yang, Yang Chen, et al. (+14)
64 [GO] 2020―Jul―28 Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe Anthony Hauser, Michel J. Counotte, Charles C. Margossian, Garyfallos Konstantinoudis, Nicola Low, Christian L. Althaus, et al. (+2)
65 [GO] 2020―Jul―21 Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study Alexandra Teslya, Thi Mui Pham, Noortje G. Godijk, Mirjam E. Kretzschmar, Martin C. J. Bootsma, Ganna Rozhnova, Yuming Guo
66 [GO] 2020―Jul―21 Can self-imposed prevention measures mitigate the COVID-19 epidemic? Lei Zhang, Yusha Tao, Mingwang Shen, Christopher K. Fairley, Yuming Guo
67 [GO] 2020―Jul―17 Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study Francesco Pinotti, Laura Di Domenico, Ernesto Ortega, Marco Mancastroppa, Giulia Pullano, Eugenio Valdano, et al. (+4)
68 [GO] 2020―Jun―30 Will COVID-19 be evidence-based medicine’s nemesis? Trisha Greenhalgh
69 [GO] 2020―Jun―16 The potential impact of COVID-19 in refugee camps in Bangladesh and beyond:  A modeling study Shaun Truelove, Orit Abrahim, Chiara Altare, Stephen A. Lauer, Krya H. Grantz, Andrew S. Azman, et al. (+2)
70 [GO] 2020―Jun―16 Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series Che Zhang, Jiaowei Gu, Quanjing Chen, Na Deng, Jingfeng Li, Li Huang, et al. (+2)
71 [GO] 2020―May―29 Pandemic preparedness and responses: WHO to turn to in a crisis?
72 [GO] 2020―May―05 Antibody-based therapies for COVID-19: Can Europe move faster? Michel D. Kazatchkine, Michel Goldman, Jean-Louis Vincent
73 [GO] 2020―Apr―28 Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks
74 [GO] 2020―Jan―09 Infectious disease pandemic planning and response: Incorporating decision analysis Freya M. Shearer, Robert Moss, Jodie McVernon, Joshua V. Ross, James M. McCaw


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.010 sec